Evaluating Quality in Clinical Cancer Research: The M.D. Anderson Cancer Center Experience

Publisher： Karger

E-ISSN： 1423-0232|77|2|75-81

ISSN： 0030-2414

Source： Oncology, Vol.77, Iss.2, 2009-07, pp. : 75-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mario A. Luna, M.D. The University of Texas M.D. Anderson Cancer Center (January 21, 1935 to November 9, 2008)

By El-Naggar Adel  

Head and Neck Pathology, Vol. 3, Iss. 2, 2009-06 ,pp. : 131-132

Humana Press, Inc

Access to resources Recommend Favorite

Greek M.D. Anderson Symptom Inventory: Validation and Utility in Cancer Patients

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 203-210

Karger

Access to resources Recommend Favorite

The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy – the MD Anderson Cancer Center experience

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 281-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy – the MD Anderson Cancer Center experience

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 281-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Localized Gastric Cancer Treated with Chemoradation without Surgery: UTMD Anderson Cancer Center Experience

By  

Oncology, Vol. 82, Iss. 6, 2012-06 ,pp. : 347-351

Karger

Access to resources Recommend Favorite